Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › TWST
FARALLON CAPITAL MANAGEMENT, L.L.C. position in TWST
TWIST BIOSCIENCE CORP · Health Care
FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 2,136,400 shares of TWST (TWIST BIOSCIENCE CORP) in its Q3 2026 13F filing — a position valued at US$412.8M, representing 1.83% of its reported portfolio and ranking #16 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TWST holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How FARALLON CAPITAL MANAGEMENT, L.L.C.'s TWST position evolved
FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in TWST in Q2 2024 at 192,000 shares (US$9.5M). The position peaked in Q3 2026 at 2,136,400 shares, worth US$412.8M. Across 10 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,136,400 shares valued at US$412.8M. Notable position changes include a 77% increase in Q3 2024 (shares rose 3% over the following quarter), a 98% trim in Q4 2024 (shares fell 16% over the following quarter), a 18562% increase in Q1 2026 (shares rose 116% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 192.00K | $9.46M | New |
| Q3 2024 | 340.65K | $15.39M | Add |
| Q4 2024 | 7.65K | $355.50K | Reduce |
| Q1 2025 | 7.65K | $300.34K | Hold |
| Q2 2025 | 7.65K | $281.44K | Hold |
| Q3 2025 | 7.65K | $215.27K | Hold |
| Q4 2025 | 7.65K | $242.66K | Hold |
| Q1 2026 | 1.43M | $67.84M | Add |
| Q2 2026 | 2.14M | $219.79M | Add |
| Q3 2026 | 2.14M | $412.84M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TWST and 13F data
TWST (TWIST BIOSCIENCE CORP) is a Health Care company. 61 other funds we track also report a position in TWST — the largest reported positions include ARK Invest (US$656.6M), Artisan Partners Limited Partnership (US$395.1M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$281.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TWST
- ARK Invest 3.40M sh · $656.64M · Q3 2026
- Artisan Partners Limited Partnership 2.04M sh · $395.05M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.45M sh · $280.99M · Q3 2026
- EdgePoint Investment Group Inc. 2.52M sh · $259.43M · Q2 2026
- Farallon Capital Management 2.14M sh · $219.79M · Q2 2026
- Stephens Investment Management Group LLC 780.42K sh · $150.81M · Q3 2026
- Amova Asset Management Americas, Inc. 776.10K sh · $149.81M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 673.17K sh · $130.08M · Q3 2026
- First Light Asset Management, LLC 727.93K sh · $74.89M · Q2 2026
- Tao Capital Management LP 189.81K sh · $36.68M · Q3 2026
More on FARALLON CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held TWST?
FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TWST holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in TWST?
As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 2.14M shares of TWST (TWIST BIOSCIENCE CORP), valued at $412.84M, representing 1.83% of its reported portfolio and ranking #16.
Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling TWST?
In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in TWST. The position peaked in Q3 2026 at 2.14M shares.
Which other funds hold TWST?
Other major institutional holders of TWST include ARK Invest, Artisan Partners Limited Partnership, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.